###begin article-title 0
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 47 68 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Inherited Glutathione Reductase Deficiency and Plasmodium falciparum Malaria-A Case Study
###end article-title 0
###begin p 1
Conceived and designed the experiments: VG ES SR RHS PA KB. Performed the experiments: VG ES SR RvZ. Analyzed the data: VG ES SR RHS KB. Contributed reagents/materials/analysis tools: ES RHS RvZ DR PA KB. Wrote the paper: VG SR RHS DR PA KB.
###end p 1
###begin p 2
###xml 3 24 3 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 836 849 836 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1651 1659 1651 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3 24 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 836 849 <span type="species:ncbi:5833">P. falciparum</span>
In Plasmodium falciparum-infected red blood cells (RBCs), the flavoenzyme glutathione reductase (GR) regenerates reduced glutathione, which is essential for antioxidant defense. GR utilizes NADPH produced in the pentose phosphate shunt by glucose-6-phosphate dehydrogenase (G6PD). Thus, conditions affecting host G6PD or GR induce increased sensitivity to oxidants. Hereditary G6PD deficiency is frequent in malaria endemic areas and provides protection against severe malaria. Furthermore, GR deficiency resulting from insufficient saturation of the enzyme with its prosthetic group FAD is common. Based on these naturally occurring phenomena, GR of malaria parasites and their host cells represent attractive antimalarial drug targets. Recently we were given the opportunity to examine invasion, growth, and drug sensitivity of three P. falciparum strains (3D7, K1, and Palo Alto) in the RBCs from three homozygous individuals with total GR deficiency resulting from mutations in the apoprotein. Invasion or growth in the GR-deficient RBCs was not impaired for any of the parasite strains tested. Drug sensitivity to chloroquine, artemisinin, and methylene blue was comparable to parasites grown in GR-sufficient RBCs and sensitivity towards paraquat and sodium nitroprusside was only slightly enhanced. In contrast, membrane deposition of hemichromes as well as the opsonizing complement C3b fragments and phagocytosis were strongly increased in ring-infected RBCs of the GR-deficient individuals compared to ring-infected normal RBCs. Also, in one of the individuals, membrane-bound autologous IgGs were significantly enhanced. Thus, based on our in vitro data, GR deficiency and drug-induced GR inhibition may protect from malaria by inducing enhanced ring stage phagocytosis rather than by impairing parasite growth directly.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 124 145 120 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 190 193 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler1">[1]</xref>
###xml 194 197 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>
###xml 303 306 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler1">[1]</xref>
###xml 307 310 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>
###xml 473 476 469 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Atamna1">[6]</xref>
###xml 568 571 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Akoachere1">[7]</xref>
###xml 592 593 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 721 731 717 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 863 866 859 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Hiller1">[8]</xref>
###xml 971 974 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker1">[3]</xref>
###xml 976 979 972 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>
###xml 1027 1040 1023 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1045 1047 1041 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pf</italic>
###xml 1126 1136 1122 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1228 1231 1224 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>
###xml 1232 1236 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Rahlfs1">[11]</xref>
###xml 1373 1376 1369 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>
###xml 124 145 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 1027 1040 <span type="species:ncbi:5833">P. falciparum</span>
The tripeptide glutathione (gamma-glutamylcysteinylglycine) is present in millimolar concentrations in the malaria parasite Plasmodium falciparum as well as in the host red blood cell (RBC) [1]-[5]. Reduced glutathione (GSH) plays an essential role in antioxidant defense in both parasite and host cell [1]-[5]. Parasite GSH supports cell growth by providing electrons for deoxyribonucleotide synthesis and takes part in detoxifying heme, a product of hemoglobin digestion [6]. Furthermore, GSH is the coenzyme of the glyoxalase system, which detoxifies methylglyoxal [7], and of glutathione S-transferase (GST)-based reactions. GSTs contribute to the detoxification of exogenous and endogenous cytotoxic metabolites. In Plasmodium, GST is involved in peroxide detoxification and the binding of parasitotoxic heme as well as in the development of drug resistance [8]. The flavoenzyme glutathione reductase (GR, EC 1.8.1.7) reduces oxidized glutathione (GSSG) back to GSH [3], [9]. Due to its central position in redox control, P. falciparum GR (PfGR) is ranked number one in the list of proposed antimalarial drug targets for Plasmodium (), and a wide range of respective drug development approaches is currently being followed [9]-[11]. In addition, the inhibition of RBC GR has been proposed as an approach to reduce the risk of multidrug resistance in malaria parasites [9].
###end p 4
###begin p 5
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler2">[2]</xref>
###xml 341 344 341 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker2">[4]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler3">[12]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Nkhoma1">[15]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler4">[16]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 1415 1419 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 650 656 <span type="species:ncbi:9606">people</span>
###xml 986 993 <span type="species:ncbi:9606">patient</span>
In the GR-catalyzed reaction, reducing equivalents are provided by NADPH. NADPH is generated in the first half of the hexose monophosphate shunt by glucose-6-phosphate dehydrogenase (G6PD). Therefore, G6PD (producer of NADPH) as well as GR (utilizer of NADPH) are equally essential to maintain GSH homeostasis in the parasite-host unit [2], [4]. Mutations affecting either G6PD or GR might thus induce similar metabolic and functional consequences in the RBC. G6PD deficiency occurs in numerous genotypes, some of which are polymorphic and particularly frequent in areas where malaria is or was endemic [12]-[14], affecting approximately 330 million people worldwide [15]. Decreased GR activity due to low saturation with FAD is also common in certain malaria-endemic regions [16]. By contrast, hereditary GR deficiency is rare [17], and only recently a full biochemical and molecular characterization of a GR mutation leading to complete GR deficiency has been performed [18]. In this patient, RBCs and leukocytes did not contain any GR activity, and the GR protein could not be detected by Western blotting. DNA sequencing revealed a 2242-bp deletion, starting at nucleotide +658 in intron 11 and ending at nucleotide 639 in the 3' untranslated region of exon 13 of the GR gene, which is located on chromosome 8. As a result, translated GR missed the complete dimerization domain, resulting in an inactive enzyme [18].
###end p 5
###begin p 6
###xml 131 141 131 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">falciparum</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ruwende1">[19]</xref>
###xml 211 224 211 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 335 348 335 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Luzzatto1">[13]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Arese1">[21]</xref>
###xml 745 749 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>
###xml 782 786 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>
###xml 211 224 <span type="species:ncbi:5833">P. falciparum</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 335 348 <span type="species:ncbi:5833">P. falciparum</span>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
In view of (a) the potentially similar metabolic effects of G6PD and GR deficiency, (b) the well documented protection from severe falciparum malaria afforded by G6PD deficiency [14], [19] and (c) the fact that P. falciparum GR and human GR represent most promising antimalarial drug targets, we studied invasion and growth of several P. falciparum strains in GR-deficient RBCs as well as the stage-dependent pathological alterations induced by parasite growth in these erythrocytes. We directly compared those changes to GR-sufficient control cells as well as to analogous data obtained with malaria-infected G6PD-deficient RBCs and to senescent RBCs [13], [20], [21]. Analogies with RBCs from patients with sickle-cell trait, beta-thalassemia [22], and pyruvate kinase deficiency [23] are discussed.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 99 106 <span type="species:ncbi:9606">patient</span>
Unless otherwise indicated, all experiments reported below were performed with RBCs from the index patient.
###end p 8
###begin title 9
###xml 31 44 <span type="species:ncbi:5833">P. falciparum</span>
Invasion and multiplication of P. falciparum grown in GR-deficient RBCs
###end title 9
###begin p 10
###xml 119 140 119 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 158 168 158 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 449 459 445 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 730 731 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 749 750 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 810 817 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007303-t001">Table 1</xref>
Twenty-four hours after inoculation of GR-deficient RBCs with malarial parasites (strains 3D7 or K1, experiment 1, see Materials and Methods), ring stages of Plasmodium were detectable in all wells. As determined by Giemsa staining and by having an experienced technician count infected cells under the light microscope, the parasitemia for the 3D7 strain was 3.9+/-0.5% in the GR-deficient cells and 4.0+/-0.4% in the controls. This indicated that Plasmodium is able to invade GR-deficient RBCs as efficiently as normal RBCs. Subsequently, parasites were grown in the respective RBC cultures for four complete 48-h cycles, showing a mean multiplication rate of 4.9+/-0.3 per RBC cycle for the GR-deficient RBCs, as well as 4.3 (0+ blood) and 6.5 (A+ blood) for the controls (mean 5.4+/-0.5; data are given in Table 1).
###end p 10
###begin title 11
###xml 51 64 51 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 51 64 <span type="species:ncbi:5833">P. falciparum</span>
Comparison of growth and biochemical properties of P. falciparum grown in GR-deficient and control RBCs.
###end title 11
###begin p 12
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 40 <span type="species:ncbi:9606">patient</span>
###xml 150 157 <span type="species:ncbi:9606">patient</span>
Experiment 1 refers to the index patient and the A+ blood group control, experiment 2 (data given in brackets or indicated as exp. 2) refers to index patient and mean values of 3 controls. All values given represent mean values +/- SEM of the different individuals included and two to three parallel determinations per sample.
###end p 12
###begin p 13
###xml 64 77 64 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 64 77 <span type="species:ncbi:5833">P. falciparum</span>
###xml 208 215 <span type="species:ncbi:9606">patient</span>
Before determining the biochemical parameters in the parasites, P. falciparum was grown over 4-5 cycles (corresponding to 8-10 days) in the respective RBCs. Control cells had the same blood group (0+) as the patient's.
###end p 13
###begin p 14
*Indicates significant differences (P<0.05) between GR-deficient cells and controls.
###end p 14
###begin p 15
###xml 48 55 48 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 81 88 <span type="species:ncbi:9606">patient</span>
###xml 498 505 <span type="species:ncbi:9606">patient</span>
###xml 583 590 <span type="species:ncbi:9606">patient</span>
Also, in the second experiment (strain 3D7, see Methods), all RBC samples (index patient and three controls) were efficiently invaded by the parasites. Forty-eight hours later about 4% infected RBCs (IRBCs) were again determined in all 4 cultures. After splitting and another 48-h cycle, a very similar parasitemia (given in the following for 3D7) was determined in all samples (9.8+/-0.3% in the GR-deficient cells, 9.3+/-0.4% in the controls). Also the percentages of ring stages (36+/-2% in the patient and 37+/-3% in the controls) and trophozoite/schizont stages (64+/-1% in the patient, 62+/-3% in the controls) did not differ significantly. The morphology of the parasites as determined by light microscopy after Giemsa staining was unchanged throughout the experiments (data not shown). In a separate set of experiments performed in the other participating laboratory in Turin with the Palo Alto parasite strain, similar data were obtained, showing that the invasion rate of GR-deficient RBCs was as high as that of control RBCs (30% parasitemia at 19 h after inoculation with 6.4% schizonts), and regular development into trophozoites was observed on day 2 (30% parasitemia).
###end p 15
###begin title 16
###xml 63 76 <span type="species:ncbi:5833">P. falciparum</span>
GR activity, total glutathione content and drug sensitivity of P. falciparum grown in GR-deficient RBCs
###end title 16
###begin p 17
###xml 592 613 592 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 821 823 821 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
Malarial parasites grown in GR-deficient RBCs were tested for total glutathione content, GR activity, and their sensitivity towards redox-active antimalarials as well as inducers of oxidative and nitrosative stress. Data were collected in two independent experiments (including venipuncture and shipment of the blood samples) with different controls and two different parasite strains (K1 and 3D7). Before determining the above parameters, parasites were grown for 4-5 cycles (corresponding to 8-10 days) in the respective RBCs. Late trophozoite stages were then isolated as described in the Materials and Methods section and directly used for the determination of GR activity and glutathione content. Antimalarial drugs and pro-oxidant agents were added to the ring stages of the parasites in order to determine their IC50 values.
###end p 17
###begin p 18
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007303-t001">Table 1</xref>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007303-t001">Table 1</xref>
In both experiments the parasites displayed a glutathione content of about 70 nmol/mg protein, which did not differ between parasites grown in GR-deficient and normal host cells (Table 1). However, in the parasites grown in GR-deficient cells, GR activity was found to be significantly reduced to 61% (experiment 1, see Table 1) of control values. A comparable value (66% of control activity) was determined in experiment 2.
###end p 18
###begin p 19
###xml 6 8 6 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 147 154 147 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007303-t001">Table 1</xref>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007303-t001">Table 1</xref>
The IC50 values for CQ, artemisinin, and methylene blue were very similar between parasites grown in GR-deficient RBCs and in normal control RBCs (Table 1). This was verified in both experiments and for both parasite strains K1 and 3D7. However, the IC50 values of the superoxide generating agent paraquat and of sodium nitroprusside were found to be significantly lower in parasites grown in GR-deficient RBCs than in controls (Table 1).
###end p 19
###begin title 20
Membrane binding of hemichromes, complement C3 fragment, autologous IgG, and phagocytosis in ring stage-infected GR-deficient RBCs
###end title 20
###begin p 21
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g001">Fig. 1A</xref>
###xml 209 216 <span type="species:ncbi:9606">patient</span>
Membrane-bound hemichromes, indicators of oxidative membrane damage and inducers of RBC membrane modifications producing enhanced phagocytosis [20]-[22], were measured in ring stage-infected RBCs of the index patient, individual 2 (brother), and individual 3 (sister), all homozygous for the GR deficiency, and were compared to ring stage-infected normal RBCs. As shown in Fig. 1A, parasite growth significantly increased membrane-bound hemichromes in all three GR-deficient individuals.
###end p 21
###begin title 22
Membrane-bound hemichromes, complement C3c fragment, and autologous IgG in GR-deficient and GR-sufficient RBCs.
###end title 22
###begin p 23
###xml 920 941 912 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 178 185 <span type="species:ncbi:9606">patient</span>
###xml 245 252 <span type="species:ncbi:9606">patient</span>
###xml 446 453 <span type="species:ncbi:9606">patient</span>
###xml 614 621 <span type="species:ncbi:9606">patient</span>
Shown are membrane-bound hemichromes (panel A), complement C3c fragment (panel B) and autologous IgG (panel C) in ring-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) and sister (individual 3) of index patient, and from normal GR-sufficient controls. Black bars indicate ring-infected RBCs; open bars, non-infected RBCs. Hemichromes are expressed as pmoles/microg membrane protein. Mean values of index patient, individuals 2 and 3, and normal controls (mean+/-SD, n = 2-4) are shown. Hemichromes were significantly higher (p<0.02) in the ring-infected RBCs of the index patient and individuals 2 and 3 compared to ring-infected RBCs of normal controls. Complement C3c fragment and autologous IgG are expressed as Mean Fluorescence Intensity. Representative data of GR-deficient individuals and mean values of normal controls (mean+/-SD, n = 2-3). For experimental details see Materials and Methods.
###end p 23
###begin p 24
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 399 378 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 421 432 421 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g001">Figure 1B&#8211;C</xref>
###xml 843 852 843 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">Figure 2A</xref>
###xml 888 897 888 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">Figure 2B</xref>
###xml 1182 1193 1182 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">Figure 2A&#8211;B</xref>
###xml 1322 1331 1322 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">Figure 2B</xref>
###xml 194 201 <span type="species:ncbi:9606">patient</span>
###xml 601 608 <span type="species:ncbi:9606">patient</span>
###xml 695 702 <span type="species:ncbi:9606">patient</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 1074 1081 <span type="species:ncbi:9606">patient</span>
Membrane binding of complement fragments C3 and C3b2 and autologous IgG, two powerful opsonins known to be instrumental in inducing phagocytosis, were assayed in ring-infected RBCs in the index patient as well as in individuals 2 and 3. Opsonic complement C3 fragments C3b/C3b2 were measured as C3c, a stable C3 derivative, making use of anti-C3c antibodies, as detailed in the Materials and Methods section. As shown in Figure 1B-C, membrane deposition of complement fragment C3c was remarkably increased in all three GR-deficient individuals, while binding of IgG was strongly enhanced in the index patient but unchanged in the other two individuals. In general, changes observed in the index patient were more pronounced compared to the other two GR-deficient individuals. Phagocytosis was assayed with the human monocytic cell line THP-1 (Figure 2A) and with human mononuclear cells (Figure 2B). Both phagocytic cell types displayed increased phagocytosis of ring-infected cells from all three GR-deficient individuals. Again the effect was more pronounced in the index patient. Co-cultivated, non-infected normal or deficient RBCs were not phagocytosed in significant amounts (Figure 2A-B). Trophozoites were phagocytosed more intensely than ring stages, with minor differences between GR-deficient and control RBCs (Figure 2B).
###end p 24
###begin title 25
Phagocytosis of GR-deficient and GR-sufficient RBCs.
###end title 25
###begin p 26
###xml 766 787 764 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 118 125 <span type="species:ncbi:9606">patient</span>
###xml 189 196 <span type="species:ncbi:9606">patient</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 364 371 <span type="species:ncbi:9606">patient</span>
###xml 409 416 <span type="species:ncbi:9606">patient</span>
###xml 642 649 <span type="species:ncbi:9606">patient</span>
Shown is the phagocytosis by THP-1 cells (panel A) of ring-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) and sister (individual 3) of the index patient, and from normal GR-sufficient controls. Phagocytosis by human monocytes (panel B) of ring- and trophozoite-infected and non-infected GR-deficient RBCs from the index patient, brother (individual 2) of the index patient, and from normal GR-sufficient controls. Black bars indicate ring-/trophozoite-infected RBCs; open bars, non-infected RBCs. Phagocytosis is expressed as the number of ingested RBCs per phagocyte. Representative data of index patient, individuals 2 and 3, and mean values of normal controls (mean+/-SD, n = 3) are shown. For experimental details see Materials and Methods.
###end p 26
###begin p 27
###xml 458 467 458 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g001">Figures 1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">2</xref>
###xml 493 502 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007303.s001">figure S1</xref>
###xml 529 538 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g001">Figures 1</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">2</xref>
The data on membrane-bound hemichromes, complement C3c fragment, IgG, and phagocytosis were obtained from single samples from the GR-deficient individuals and 3-4 normal controls. Except for hemichromes where 3-4 repeats were constantly performed and formal statistical treatment was possible, the paucity of sample material did not allow us to perform a sufficient number of repeats in the GR-deficient samples. Therefore representative values are shown in Figures 1 and 2. The supplementary figure S1 compares results shown in Figures 1 and 2 with an additional series of normal control rings obtained using 24-36 h old normal blood from 7 healthy Italian donors. In general, SDs were distinctly lower in the Italian control series, increasing the robustness of comparisons.
###end p 27
###begin title 28
Discussion
###end title 28
###begin title 29
RBC mutations leading to enhanced ring phagocytosis
###end title 29
###begin p 30
###xml 205 215 205 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">falciparum</italic>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Williams1">[24]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-MinOo1">[26]</xref>
###xml 334 338 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Arie1">[27]</xref>
###xml 340 344 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Tokumasu1">[28]</xref>
###xml 351 355 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Chotivanich1">[29]</xref>
###xml 384 388 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Greene1">[14]</xref>
###xml 390 394 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 413 417 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>
###xml 488 492 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 494 498 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>
###xml 683 687 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>
###xml 865 869 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 871 875 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>
###xml 877 881 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>
###xml 1170 1174 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Turrini1">[30]</xref>
###xml 1673 1677 1670 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 1678 1682 1675 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi2">[23]</xref>
###xml 1881 1885 1876 1880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Arese1">[21]</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 1812 1817 <span type="species:ncbi:9606">human</span>
A relatively small number of mutations affecting hemoglobins and RBC enzymes are present in large numbers in human populations. It is accepted that these widespread polymorphisms afford protection against falciparum malaria [24]-[26]. A group of these conditions including sickle cell anemia, beta-thalassemia, possibly hemoglobins C [27], [28] and E [29], as well as G6PD deficiency [14], [20] and PK deficiency [23] appear to provide antimalarial protection based on a common mechanism [20], [22]. The aberrant RBCs are characterized by an increased production of reactive oxygen species (ROS) (hemoglobin mutants), or decreased antioxidant defense (G6PD deficiency, PK deficiency [23]). Non-infected, mutant RBCs display slight but significantly increased membrane deposition of hemichromes accompanied by low-grade but distinct enhancement of phagocytic uptake [20], [22], [23]. Parasites growing in any of the aforementioned mutated cells induce typical modifications in the host RBCs which start manifesting at ring stage. Normal RBCs harboring ring stages show little band 3 aggregation, poor opsonization, and slightly enhanced phagocytic recognition and uptake [30]. By contrast, rings growing in mutant RBCs sequentially display (1) remarkably enhanced hemichrome deposition on the membrane, (2) oxidative band 3 aggregation, (3) increased affinity for naturally circulating IgG - notably anti-(band 3) IgG, (4) activation of the complement system and generation of C3 opsonic fragments, (5) opsonization by increased deposition of autologous IgG and C3 opsonic fragments, and finally (6) remarkably enhanced recognition and phagocytosis by monocytes/macrophages [20]-[23]. This sequence of events, eventually resulting in enhanced phagocytic uptake, is very similar to changes occurring in the normal human RBC during the very last phase of its lifespan of 120+/-4 days [21].
###end p 30
###begin title 31
###xml 57 64 <span type="species:ncbi:9606">patient</span>
Advantages of enhanced ring phagocytosis for the malaria patient
###end title 31
###begin p 32
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 245 249 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Williams1">[24]</xref>
###xml 251 255 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Roberts1">[25]</xref>
###xml 266 269 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 392 396 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schwarzer1">[31]</xref>
###xml 531 535 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schwarzer1">[31]</xref>
###xml 589 593 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Hnscheid1">[32]</xref>
###xml 648 652 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Fiori1">[33]</xref>
###xml 740 744 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schwarzer2">[34]</xref>
###xml 780 784 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Scorza1">[35]</xref>
###xml 1091 1095 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Skorokhod1">[36]</xref>
###xml 1097 1101 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Chakravorty1">[37]</xref>
###xml 1351 1355 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cholera1">[38]</xref>
###xml 1357 1361 1354 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Fairhurst1">[39]</xref>
###xml 1375 1379 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Fairhurst2">[40]</xref>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
Enhanced and preferential phagocytosis of ring-parasitized mutant RBCs may be advantageous to the host in two ways: (i) via reduction of parasite growth and parasite density, observed for example in patients with HbAS and beta-thalassemia trait [24], [25], and (ii) via rapid digestion of phagocytosed rings by monocytes and the frequent repetition of this process without loss of efficiency [31]. By contrast, phagocytosis of hemozoin-containing mature parasites inhibits the ability of monocytes to repeat the phagocytic process [31], enhances their production of inflammatory cytokines [32], and impairs their ability to kill ingested pathogens [33], to express MHC class II and other membrane antigens upon interferon-gamma stimulation [34], and to correctly present antigens [35]. Another way enhanced ring phagocytosis may be advantageous to the host is by lowering the number of trophozoites and schizonts adhering to endothelia in specific organs and provoking there severe clinical conditions such as cerebral malaria, placental malaria, and possibly dyserythropoiesis-based anemia [36], [37]. Other protection mechanisms probably concur with this based on enhanced ring-phagocytosis of mutant RBCs underscored here. For example, decreased adhesion to endothelia has been suggested to be involved in anti-malaria defense in sickle-cell trait [38], [39] and Hb AC/CC [40].
###end p 32
###begin title 33
###xml 50 63 <span type="species:ncbi:5833">P. falciparum</span>
ApoGR-deficient red blood cells as host cells for P. falciparum
###end title 33
###begin p 34
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Arese2">[41]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 1360 1387 1360 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9, and references therein]</xref>
###xml 1513 1521 1513 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1578 1580 1578 1580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1993 1995 1993 1995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pf</italic>
###xml 2008 2011 2008 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker2">[4]</xref>
###xml 2013 2016 2013 2016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker3">[5]</xref>
###xml 2099 2103 2099 2103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KomakiYasuda1">[42]</xref>
###xml 2167 2169 2167 2169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 2397 2405 2397 2405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
GR deficiency and G6PD deficiency might show similar characteristics as far as instability and impaired regeneration of GSH from GSSG is concerned [41], [17]. However, G6PD deficiency may have more severe functional consequences for the RBC than GR deficiency, since insufficient formation of NADPH leads to an inadequate supply of reducing equivalents to both the glutathione and the thioredoxin system, whereas the absence of GR activity in non-parasitized RBCs is obviously well compensated [18]. As indicated already by previous studies, rather stable GSH concentrations are present in the non-parasitized RBCs [17]. This might be due to enhanced GSH synthesis [17] but could also be the result of upregulation of the pentose phosphate shunt and by components of the thioredoxin system. Also in the host-parasite unit, the absence of RBC GR seems to be well tolerated under cell culture conditions and in the absence of oxidative stressors. This is shown by normal invasion and growth as well as by comparable glutathione levels detected in both parasites grown in GR-deficient and normal RBCs. Interestingly, GR activity was found to be downregulated by 40% in the parasite compartment. The observation that this decrease is not reflected in the glutathione levels can be explained by the fact that GR is working intracellularly with large spare capacity [9, and references therein]. This phenomenon, however, needs to be studied in further detail. An efficient adaptation to the lack of host cell GR in our in vitro system was furthermore supported by the fact that the IC50 values for CQ, artemisinin, and methylene blue were very similar when comparing parasites grown in GR-deficient RBCs and in GR-sufficient control RBCs. All three antimalarial drugs are known to interfere with redox metabolism: CQ inhibits heme polymerization, leading to enhanced oxidative stress; artemisinin as an endoperoxide is able to increase ROS concentrations; methylene blue is a known redox cycler and PfGR inhibitor [4], [5]. Only when incubating parasitized RBCs with micromolar concentrations of paraquat [42] or of the nitric oxide releasing agent sodium nitroprusside, IC50 values were significantly lower in parasites grown in GR-deficient RBCs than in the controls. This result suggests that it might be possible to demonstrate the higher redox susceptibility of GR-deficient parasitized RBCs in an in vitro assay by imposing oxidative or nitrosative stress.
###end p 34
###begin title 35
Enhanced ring phagocytosis associated with GR deficiency
###end title 35
###begin p 36
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 257 270 257 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 257 270 <span type="species:ncbi:5833">P. falciparum</span>
###xml 767 774 <span type="species:ncbi:9606">patient</span>
Data presented here show that malaria-infected GR-deficient RBCs behave very similarly to infected G6PD-deficient RBCs [20]. First, GR-deficient RBCs were invaded by parasites, and they supported the growth and multiplication of CQ-sensitive and -resistant P. falciparum strains in a manner similar to normal RBCs. Second, as expected from the enhanced sensitivity to oxidation, infection enhanced heme and hemichrome deposition in deficient RBCs by a factor of approximately 3. Third, membrane deposition of opsonins such as C3 complement fragments and autologous IgG, and phagocytosis, were also found to be increased when ring stages were grown in GR-deficient RBCs. The two other homozygous GR-deficient individuals examined here (brother and sister of the index patient) also showed enhanced binding of C3 complement fragment and increased phagocytosis whereas IgG binding was not increased. These differences remain to be elucidated in further detail. All three individuals studied were identical with respect to the complete lack of GR activity. However, other metabolic or immunologic states and predispositions, which we do not know and therefore cannot control, might lead to the observed differences.
###end p 36
###begin title 37
Endemic GR deficiency caused by undersaturation with FAD
###end title 37
###begin p 38
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Beutler3">[12]</xref>
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schulz1">[43]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ahmed1">[44]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Rohner1">[45]</xref>
###xml 632 642 632 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Das1">[46]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kaikai1">[47]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Anderson1">[48]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Anderson1">[48]</xref>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref>
###xml 1260 1264 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Anderson3">[50]</xref>
###xml 1377 1381 1374 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Siniscalco1">[51]</xref>
###xml 1534 1538 1528 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-ElHazmi1">[52]</xref>
###xml 1539 1543 1533 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Varma1">[55]</xref>
###xml 130 136 <span type="species:ncbi:9606">humans</span>
###xml 658 664 <span type="species:ncbi:9606">humans</span>
Complete absence of RBC GR is very rare [12], [17], [18]. This defect evidently did not arise in parallel to malaria expansion in humans to provide protection. However, impairment of GR activity is widespread and geographically coincident with past or present occurrence of malaria. Since GR is a flavoprotein critically dependent on FAD [43], flavin-deficient RBCs would contain decreased GR activity. In fact, riboflavin deficiency is widespread in underdeveloped countries due to low dietary intake [44], [45]. Several studies have shown that a reduced riboflavin status and non-genetic low GR activity are associated with lower Plasmodium parasitemia in humans [46] and in animal [47] models and are frequently found in malaria-endemic areas [48]. Furthermore, high prevalence of familial flavin-deficient RBCs not due to dietary riboflavin deficiency was detected in parts of Italy where malaria used to be prevalent, namely the Maremma region in Tuscany, the delta region of the river Po, and coastal areas in Sardinia [48]-[50]. Interestingly, in Sardinia [50] micro-regional accumulation in villages formerly exposed to malaria was observed for carriers of the putative malaria-protective low-activity GR and FMN-dependent pyridoxine phosphate oxidase [50]. Accumulation in the same villages was previously observed for carriers of beta-thalassemia and G6PD deficiency [51]. Finally, low GR activity was found to be frequently associated with other malaria-protective mutations such as sickle-cell anemia and beta-thalassemia [52]-[55].
###end p 38
###begin title 39
Conclusions
###end title 39
###begin p 40
###xml 542 545 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-KrauthSiegel1">[9]</xref>
###xml 701 723 701 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum in vitro</italic>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Zhang1">[56]</xref>
###xml 1075 1082 1075 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1086 1094 1086 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1184 1188 1184 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Frischer1">[57]</xref>
###xml 701 714 <span type="species:ncbi:5833">P. falciparum</span>
In conclusion, rare RBC mutations such as PK deficiency and GR deficiency resist malaria infection and may provide protection by the same paradigm applicable to widespread mutations such as those affecting hemoglobin, G6PD, or membrane proteins. Thus the pharmacologic inhibition of parasite and/or host cell GR might lead to metabolic consequences proven by nature to be effective against the parasite. Indeed the inhibition of RBC GR has been proposed as a feasible antimalarial approach likely to reduce the risk of resistance development [9]. Normal RBCs pretreated with high doses of the cytostatic agent carmustine (BCNU) have no detectable GR activity. These RBCs do not serve as host cells of P. falciparum in vitro unless the medium contains high levels of glutathione. Thus, in contrast to genetically GR-deficient RBCs, RBCs rendered GR-deficient by BCNU appear to be unable to maintain sufficient GSH levels, possibly because the high BCNU doses also affect the GSH synthesizing enzymes [56]. Nevertheless erythrocytes pretreated with lower doses of nitrosoureas in vivo or in vitro are probably suitable for corroborating and extending the findings of this present study [57].
###end p 40
###begin p 41
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
When testing GR-inhibitors as antiplasmodial agents it should be taken into account that the effects on parasite growth and multiplication in vitro might be less pronounced than in vivo - as observed in genetic GR deficiency. Thus additional tests such as parallel application of oxidant stressors and/or determination of membrane alterations and phagocytosis should be performed for assessing the antimalarial effects of GR inhibitors. Furthermore their hemolytic potential needs to be evaluated carefully.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 43
###begin p 44
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 591 598 591 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 615 623 615 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 17 24 <span type="species:ncbi:9606">patient</span>
###xml 37 44 <span type="species:ncbi:9606">patient</span>
###xml 114 119 <span type="species:ncbi:9606">woman</span>
###xml 199 206 <span type="species:ncbi:9606">patient</span>
###xml 283 293 <span type="species:ncbi:3906">fava beans</span>
###xml 342 349 <span type="species:ncbi:9606">patient</span>
The GR-deficient patient - the index patient - who kindly agreed to donate blood for this study was a 54-year old woman whose clinical history has been described before [17], [18]. She was the index patient in a family with GR deficiency who suffered a hemolytic crisis after eating fava beans. Two siblings - brother and sister of the index patient, indicated as individual 2 and individual 3, respectively - were also homozygous for GR deficiency [17]. In all three individuals GR activity in RBCs and leukocytes was undetectable and could not be stimulated by either riboflavin ingestion in vivo or FAD addition in vitro[18].
###end p 44
###begin p 45
###xml 295 303 <span type="species:ncbi:9606">patients</span>
All family members included in this study are fully aware of their unique enzyme deficiency and have given their written consent for the research carried out. The research has been explained to them both in written and oral form. The research was performed as part of the diagnostic work on the patients' blood samples, which is fully approved by the Sanquin Ethical Medical Committee.
###end p 45
###begin title 46
GR activity in GR-deficient, non-infected RBCs and GR-deficient leukocytes
###end title 46
###begin p 47
###xml 280 282 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 404 406 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 428 432 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 694 696 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 708 712 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Kamerbeek1">[18]</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 345 352 <span type="species:ncbi:9606">patient</span>
###xml 494 501 <span type="species:ncbi:9606">patient</span>
###xml 606 613 <span type="species:ncbi:9606">persons</span>
As previously reported, the GR activity in the patients' non-infected RBCs was below the detection limit of our assay, while leukocytes had 15% of normal activity. However, taking into account the basal NADPH oxidation rate measured in the absence of GSSG (14-63 micromoles/min/1011 cells at 25degreesC), only minimal GR activity was present in patient's or her siblings' leukocytes (<5 micromoles/min/1011 cells at 25degreesC) [18]. Furthermore neither non-infected RBCs nor leukocytes of the patient or her siblings contained detectable amounts of GR protein. In direct comparison, healthy adult control persons (n = 100) had GR activities of 2.7-5.8 IU/g hemoglobin in RBCs and 118-164 IU/1011 leukocytes [18].
###end p 47
###begin p 48
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Loos1">[17]</xref>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
GSH levels were already measured and reported for the GR-deficient patients in 1976. GSH was measured in the red cells of all family members and found to be normal, with values of 56-63 mg of GSH per 100 ml of packed red cells [17].
###end p 48
###begin title 49
Preparation and shipment of blood samples
###end title 49
###begin p 50
###xml 62 75 62 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 504 517 504 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 62 75 <span type="species:ncbi:5833">P. falciparum</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 340 347 <span type="species:ncbi:9606">persons</span>
###xml 504 517 <span type="species:ncbi:5833">P. falciparum</span>
For the studies performed in Giessen (infection by 3D7 and K1 P. falciparum strains, parasite cultivation, synchronization, invasion and multiplication studies, determination of glutathione and enzyme activities in parasites, drug sensitivity tests), EDTA-blood samples were taken from the patients and from hematologically healthy control persons in the Netherlands, immediately shipped to Germany on crushed ice, and utilized within 24 h. For the studies performed in Turin (infection by the Palo Alto P. falciparum strain and parasite cultivation, invasion and multiplication studies, synchronization of parasite cultures and stage-dependent separation of infected RBCs, quantification of membrane-bound total heme, hemichromes, IgG and complement C3c fragment, assay of phagocytosis with stage-separated infected and control RBCs), full blood from the GR-deficient individuals and three normal controls was anticoagulated with CPD, shipped on crushed ice, and utilized within 24 h of venipuncture. The further processing of the blood samples is described below.
###end p 50
###begin title 51
###xml 15 28 <span type="species:ncbi:5833">P. falciparum</span>
Cultivation of P. falciparum and preparation of parasite extracts
###end title 51
###begin p 52
###xml 95 108 95 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Trager1">[58]</xref>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 404 405 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 603 604 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 611 612 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 622 623 612 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 732 736 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Lambros1">[59]</xref>
###xml 936 949 926 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1139 1140 1129 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1143 1144 1133 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1154 1155 1144 1145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1157 1158 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1171 1172 1161 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1206 1207 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 95 108 <span type="species:ncbi:5833">P. falciparum</span>
###xml 369 376 <span type="species:ncbi:9606">patient</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 435 441 <span type="species:ncbi:9913">bovine</span>
###xml 936 949 <span type="species:ncbi:5833">P. falciparum</span>
In the Giessen lab CQ sensitive (3D7-Netherlands) and resistant (K1-Southeast Asia) strains of P. falciparum were grown in continuous culture as described [58] with slight modifications. Parasites were maintained at 1-10% parasitemia and 3.3% hematocrit in RPMI 1640 culture medium supplemented with A+ RBCs (normal culture conditions) or 0+ RBCs (for the GR-deficient patient and a control sample), 4% A+ human serum, 0.2% lipid-rich bovine serum albumin (Albumax), 9 mM glucose, 0.2 mM hypoxanthine, 2.1 mM L-glutamine, and 22 microg/ml gentamicin. All incubations were carried out at 37degreesC, 3% O2, 3% CO2 and 94% N2. Synchronization of parasites in culture to ring stages was carried out by treatment with 5% (w/v) sorbitol [59]. The morphology of the parasites as well as the multiplication rate were determined by light microscopy after Giemsa staining. Before determining either the glutathione content or the GR activity in P. falciparum, parasites were grown over 5 cycles (10 days) in their respective RBCs. Trophozoite stage parasites were then isolated by suspending the RBCs in a 20-fold volume of buffer containing 7 mM K2HPO4, 1 mM NaH2PO4, 11 mM NaHCO3, 58 mM KCl, 56 mM NaCl, 1 mM MgCl2, 14 mM glucose, and 0.02% saponin for 10 min at 37degreesC. The pellets were washed two times in the same saponin buffer for RBC lysis and one time in PBS (centrifugation for all steps 1,500 g, 5 min, room temperature). The free parasites were finally diluted in PBS and disrupted by freezing and thawing three times in the presence of protease inhibitors (40 microl/ml Complete (Roche) and 1 mg/ml Pefabloc (Roche)). After centrifugation (ultracentrifuge 100,000 g, 30 min, 4degreesC), the protein content of the supernatant was determined by the Bradford method and the extract was used for the various analyses.
###end p 52
###begin title 53
###xml 31 44 <span type="species:ncbi:5833">P. falciparum</span>
Invasion and multiplication of P. falciparum grown in GR-deficient RBCs
###end title 53
###begin p 54
###xml 16 29 16 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 16 29 <span type="species:ncbi:5833">P. falciparum</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
To determine if P. falciparum can successfully invade and multiply in GR-deficient RBCs, EDTA full blood was taken from patients and controls in the Netherlands and shipped at 4degreesC to the Giessen lab. About 24 h after venipuncture, plasma and buffy coat of the blood samples were removed by centrifugation (1,500 g) and aspiration followed by washing three times in a 10-fold volume of RPMI 1640 medium (1,500 g, 3 min, 4degreesC). For some of the invasion studies control samples freshly taken in Germany were processed and studied in parallel.
###end p 54
###begin p 55
###xml 58 59 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 94 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 101 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 48 55 <span type="species:ncbi:9606">patient</span>
EXPERIMENT 1: Ten microl of RBCs from the index patient (0+ blood) and two German controls (A+ and 0+ blood) each were added to 300 microl of complete cell culture medium in 48-well plates. Two microl of parasitized RBCs (3D7, mainly trophozoite stage; final parasitemia 0.7%) were added to the RBC cultures. The K1 strain was inoculated for drug sensitivity tests.
###end p 55
###begin p 56
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 67 <span type="species:ncbi:9606">patient</span>
EXPERIMENT 2: In a separate experiment, RBCs from the index patient (0+ blood) were shipped together with 3 controls (0+, A+, A+ blood). After washing, 0.5 ml of RBCs were added to 15 ml of cell culture medium and inoculated with 1 ml of parasitized RBCs (3D7, synchronized to ring stages; this resulted in the same final parasitemia of 0.7% as in experiment 1).
###end p 56
###begin title 57
Determination of total glutathione and PfGR activity in parasite extracts
###end title 57
###begin p 58
###xml 352 356 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Becker4">[60]</xref>
###xml 453 466 449 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 468 470 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pf</italic>
###xml 702 706 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Nordhoff1">[61]</xref>
###xml 453 466 <span type="species:ncbi:5833">P. falciparum</span>
For the determination of total glutathione content, 40 microl of parasite extract was deproteinized by adding 2 vol of 5% (w/vol) sulfosalicylic acid; the samples were mixed and centrifuged, and the supernatant was used for analyses. The glutathione content was measured by the GR-coupled 5,5'-dithio-bis(2-nitrobenzoic acid, DTNB)-GSH-recycling assay [60]. A standard curve was prepared using appropriate concentrations of GSH and sulfosalicylic acid. P. falciparum (Pf)GR activity in the parasite extracts was assayed at 25degreesC with 100 microM NADPH and 1 mM GSSG in 47 mM potassium phosphate, 200 mM KCl, 1 mM EDTA, pH 6.9. The consumption of NADPH was followed spectrophotometrically at 340 nm [61]. Specific activities (micromol/min/mg of protein) were calculated using the enzyme activities at 25degreesC and the protein concentrations of the parasite extracts.
###end p 58
###begin title 59
###xml 16 29 <span type="species:ncbi:5833">P. falciparum</span>
Drug effects on P. falciparum
###end title 59
###begin p 60
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Desjardins1">[62]</xref>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Fivelman1">[63]</xref>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 751 752 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1066 1079 1062 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 1095 1097 1091 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1170 1171 1166 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1219 1223 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Fivelman1">[63]</xref>
###xml 1066 1079 <span type="species:ncbi:5833">P. falciparum</span>
An isotopic drug sensitivity assay using the semi-automated microdilution technique [62] was employed to investigate the effects of CQ, artemisinin, methylene blue, paraquat and sodium nitroprusside (SNP) on parasites grown in GR-deficient RBCs. The method is based on the incorporation of radioactive 3H-hypoxanthine - which is taken up by the parasite as a precursor of purine deoxynucleotides for DNA and RNA synthesis - and was modified according to Fivelman [63]. In 96-well microtiter plates (NuncR), a two-fold serial dilution of the starting concentration of each drug to be tested was carried out. Parasites were incubated at a parasitemia of 0.125% (>70% ring forms) and 1.25% hematocrit in hypoxanthine-free medium. After 48 h, 0.5 microCi 3H-hypoxanthine was added into each well and the plates were incubated for another 24 h. The cells from each well were harvested on a glass fiber filter (Perkin-Elmer, Rodgau-Jugesheim, Germany), washed, and dried. Their radioactivity in counts per min was considered to be proportional to the respective growth of P. falciparum in the well. IC50 values (drug concentrations that produce 50% reduction in the uptake of 3H-hypoxanthine) were calculated as described in [63].
###end p 60
###begin p 61
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
For statistical analyses of the data on multiplication rates, biochemical parameters and IC50 values (given as mean values +/- SEM), the unpaired t-test as well as the Mann-Whitney U Test were employed.
###end p 61
###begin title 62
Stage-dependent separation and opsonization of parasites
###end title 62
###begin p 63
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycoplasma-</italic>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Turrini1">[30]</xref>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 524 525 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1545 1546 1543 1544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 13 <span type="species:ncbi:5833">P. falciparum</span>
###xml 460 465 <span type="species:ncbi:9606">human</span>
###xml 1991 1996 <span type="species:ncbi:9606">human</span>
P. falciparum parasites (Palo Alto strain, Mycoplasma-free) were cultivated in normal and GR- deficient RBCs at 2% hematocrit and synchronized as described [30]. Briefly, schizont stage infected normal RBCs (parasitemia >95%) were mixed for invasion with washed GR-deficient or normal RBCs and kept in growth medium (RPMI 1640, containing 25 mM Hepes, 30 mM glucose, 2 mM glutamine, 0.02 mM adenine, 24 mM NaHCO3, 32 mg/l gentamicin, and 10% A+ decomplemented human plasma) (time 0). After 19 h incubation in a humidified CO2/air incubator, the ring-enriched fraction was separated on and collected from a discontinuous 40/80/90% Percoll gradient, containing mannitol (6% wt/vol). The bottom Percoll fraction contained non-infected RBCs and approximately 15-20% rings, morphologically identical to those of the ring-enriched fraction. After 41 h incubation the trophozoite-enriched fraction was separated onto and collected from a discontinuous 10/40/80% Percoll gradient. Rings (after 19 h incubation) as well as trophozoites (after 41 h incubation) were enriched to approx. 80-85% and approx. 90%, respectively, by the above procedure. Parasitemia and parasite morphology were assessed by light microscopy after Diff-Quik(R) Fix staining (Medion Diagnostics GmbH, Dudingen, Switzerland). Non-infected control RBCs of each donor were incubated and treated in a similar way without schizont inoculation at time 0. Infected and non-infected RBCs were washed, rejuvenated for 1 h in PBS-G, and opsonized with freshly drawn serum of a healthy AB/Rh+-donor in a ratio: RBCs/PBS containing 2 mM glucose (PBS-G)/serum 1/1/2 (vol/vol). Non-opsonized RBCs were incubated in parallel substituting serum with PBS-G. After 30 min at 37degreesC cells (ring-enriched, trophozoite-enriched or non-infected RBCs) were washed 3 times with PBS-G, adjusted to 50% hematocrit and analyzed by FACS for surface-bound IgG and complement C3c fragment, and utilized for the phagocytosis assays with THP-1 cells and human peripheral monocytes. Total heme and hemichromes were measured in hypotonic ghosts prepared from the bottom Percoll fraction of the unseparated, infected GR-deficient and normal RBCs (see below). The latter procedure was due to the paucity of the ring material obtained by the enriched ring fraction (approx. 30-40 microl per individual) sufficient to perform cytofluorimetric studies but not sufficient for ghost preparation.
###end p 63
###begin title 64
Quantification of membrane-bound total heme and hemichromes in ghosts prepared from stage-separated infected RBCs
###end title 64
###begin p 65
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Steck1">[64]</xref>
###xml 322 326 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Ayi1">[22]</xref>
###xml 958 962 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schwarzer3">[65]</xref>
###xml 1089 1096 1069 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 1237 1243 1217 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1243 1247 1223 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Cappadoro1">[20]</xref>
###xml 1445 1452 <span type="species:ncbi:9606">patient</span>
Heme bound to the cytoplasmic face of the membrane as hemoglobin and insoluble hemichromes was analyzed in the hypotonic ghosts [64] prepared under non-reducing conditions in the presence of Complete(R) protease inhibitor cocktail from the bottom Percoll fraction of the unseparated, infected GR-deficient and normal RBCs [22]. This fraction contained approximately 15-20% rings. Every ghost preparation was divided into two aliquots. A first aliquot of 10 microl ghosts was solubilized for 3 h at 4degreesC in 1 ml of 0.1 N NaOH containing 3 mM EDTA and 0.05% (vol/vol) Triton X100 to quantify the total heme content (hemoglobin + insoluble hemichromes). A second aliquot of 10 microl ghosts was solubilized for 1 h at room temperature in 1 ml of PBS containing 3 mM EDTA and 0.05% (vol/vol) Triton X100 and used to quantify hemoglobin. Heme from both ghost aliquots was quantified by measuring the heme-dependent luminol-enhanced luminescence as described [65]. Each luminescence measurement (2 microL aliquots) was repeated 3-4 times. Inter-measurement variability never exceeded 2-3%. Results obtained from cell samples that contained approx. 15-20% rings were extrapolated to 100% rings using the calculation suggested by Cappadoro et al.[20]. The hemichrome content was calculated from the difference between total heme and hemoglobin heme. Hemichrome heme was the major component of total heme in control rings (88% of total heme), index patient (96%), individual 2 (89%) and individual 3 (87%), while membrane-bound hemoglobin was a minor fraction of total heme.
###end p 65
###begin title 66
Quantification of complement C3c fragment and IgG by flow cytometry
###end title 66
###begin p 67
###xml 380 381 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 395 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Lutz1">[66]</xref>
###xml 184 190 <span type="species:ncbi:9986">rabbit</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 552 558 <span type="species:ncbi:9986">rabbit</span>
###xml 578 582 <span type="species:ncbi:9925">goat</span>
Ten million ring- or trophozoite-infected and non-infected normal or GR-deficient RBCs were incubated for 30 min at room temperature in 50 microl of PBS-G, with or without the primary rabbit anti-human complement C3c fragment antibody or anti-human IgG antibody (Sigma, Milano, Italy), at a 1:400 dilution, respectively. Complement C3c fragment is the stable derivative of C3b/C3b2 opsonins [66]. Thereafter infected RBCs and non-infected controls were washed twice, suspended in 50 microl PBS-G, and incubated for 30 min at room temperature with anti-rabbit IgG-FITC antibody (goat) at 1:400. At the end of the incubation, cells were washed twice with 200 microl PBS-G, suspended in PBS-G, and analyzed on a BD FACSCalibur Flow Cytometer using Cell Quest software (BD Biosciences). Events were displayed on green fluorescence (FL1) versus forward scatter (FSC) dot plots or FL1 versus events number histogram. RBCs were gated on light scatter characteristics, and a total of at least 30,000 events in gating were collected for each sample. Data analysis was done with WinMDI software.
###end p 67
###begin title 68
###xml 77 82 <span type="species:ncbi:9606">human</span>
Phagocytosis of stage-separated infected and control RBCs by THP-1 cells and human mononuclear cells
###end title 68
###begin p 69
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
The phagocytosis assay was performed utilizing the human monocytic cell line THP-1 or human mononuclear cells.
###end p 69
###begin p 70
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1130 1131 1112 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 116 122 <span type="species:ncbi:9913">bovine</span>
1. THP-1 cells were maintained at 0.2x106 cells/ml in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 microg/ml streptomycin. The phagocytic ability of THP-1 cells was stimulated by supplementing IFN-gamma (50 U/ml) and TNF (250 U/ml) to the cell suspension 30 h before the start of phagocytosis. Shortly before phagocytosis, cells were washed three times with RPMI 1640 medium and resuspended in Macrophage-SFM medium supplemented with 10% heat-inactivated FBS to obtain 150,000 cells/300 microl medium. Ring- or trophozoite-infected and non-infected normal or GR-deficient RBCs were fluorescent-labeled for the phagocytosis assay during 10 min incubation at room temperature with 0.5 microM carboxyfluorescein diacetate, succinimidyl ester, (CFDA-SE, Sigma, Milano, Italy) in PBS-G at 0.05% hematocrit. Labeling was stopped by adding 2 ml of heat-inactivated FBS for 5 min. RBCs were then washed three times with PBS-G and co-incubated with THP-1 cells at a THP-1:RBC- ratio of 1:100 in round-bottom polypropylene tubes at 37degreesC for 2.5 h (CO2 5%). At the end of the incubation, non-ingested RBCs were lysed with 3.5 ml of ice-cold distilled water for 2 min. Physiologic osmolarity was restored by adding 10-times concentrated PBS. Cells were finally washed with cold PBS +1% FBS and analyzed with a BD FACSCalibur Flow Cytometer using Cell Quest software (BD Biosciences). Events were displayed on green fluorescence (FL1) versus forward scatter (FSC) dot plots or FL1 versus events number histogram. THP-1 live cells were gated on light scatter characteristics, and a total of at least 30,000 events in gating were collected for each sample. Data analysis was done with WinMDI software.
###end p 70
###begin p 71
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Skorokhod2">[67]</xref>
###xml 452 453 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007303-Schwarzer3">[65]</xref>
###xml 3 8 <span type="species:ncbi:9606">Human</span>
2. Human mononuclear cells were separated by Ficoll separation from buffy coats of healthy donors freshly discarded from the local blood bank, suspended in Macrophage-SFM medium (Invitrogen, Carlsbad, CA), and adhered to 24-well cell culture plates as described [67]. Phagocytosis was started by the addition of 100 opsonized ring- or trophozoite-infected or non-infected normal or GR-deficient RBCs per monocyte, stopped after 3 h incubation in the CO2-incubator, and non-ingested RBCs were removed by lysis and 4 washing steps. Phagocytosis was quantified by measuring the heme-dependent luminol-enhanced luminescence of ingested hemoglobin-heme as described [65].
###end p 71
###begin title 72
Supporting Information
###end title 72
###begin p 73
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g001">Figure 1</xref>
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007303-g002">Figure 2</xref>
Membrane-bound hemichromes, phagocytosis, complement C3c fragment, and autologous IgG in/of GR-deficient and GR-sufficient RBCs - comparison with healthy Italian donors. Data from Figure 1 and Figure 2 of the manuscript were compared to ring-infected and non-infected GR-sufficient control RBCs prepared from 24-36 h old blood (kept at +4degreesC) from 7 healthy Italian donors. Mean values of normal controls (mean+/-SD, n = 7).
###end p 73
###begin p 74
(1.65 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
The authors thank Denisa Baci, Elisabeth Fischer and Marina Fischer for their excellent technical assistance, and Milena Maule for help with the statistics of the Turin data.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Composition of the erythrocyte.
###end article-title 78
###begin article-title 79
Energy metabolism and maintenance of erythrocytes.
###end article-title 79
###begin article-title 80
###xml 62 83 62 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 62 83 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Glutathione-functions and metabolism in the malarial parasite Plasmodium falciparum.
###end article-title 80
###begin article-title 81
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
###end article-title 81
###begin article-title 82
Oxidative stress and antioxidant defense in malarial parasites.
###end article-title 82
###begin article-title 83
Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells.
###end article-title 83
###begin article-title 84
###xml 61 82 61 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 61 82 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
###end article-title 84
###begin article-title 85
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum glutathione S-transferase-structural and mechanistic studies on ligand binding and enzyme inhibition.
###end article-title 85
###begin article-title 86
Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia.
###end article-title 86
###begin article-title 87
Structure-Based Drug Development Against Malaria.
###end article-title 87
###begin article-title 88
Interference with redox-active enzymes as a basis for the design of antimalarial drugs.
###end article-title 88
###begin article-title 89
Glucose-6-phosphate dehydrogenase deficiency and other red cell enzyme abnormalities.
###end article-title 89
###begin article-title 90
Glucose-6-phosphate dehydrogenase deficiency.
###end article-title 90
###begin article-title 91
###xml 38 48 38 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">falciparum</italic>
G6PD deficiency as protection against falciparum malaria: an epidemiologic critique of population and experimental studies.
###end article-title 91
###begin article-title 92
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
###end article-title 92
###begin article-title 93
G6PD: population genetics and clinical manifestations.
###end article-title 93
###begin article-title 94
###xml 48 53 <span type="species:ncbi:9606">human</span>
Familial deficiency of glutathione reductase in human blood cells.
###end article-title 94
###begin article-title 95
###xml 55 60 <span type="species:ncbi:9606">human</span>
Molecular basis of glutathione reductase deficiency in human blood cells.
###end article-title 95
###begin article-title 96
Glucose-6-phosphate dehydrogenase deficiency and malaria.
###end article-title 96
###begin article-title 97
###xml 101 122 101 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 101 122 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
###end article-title 97
###begin article-title 98
###xml 90 95 <span type="species:ncbi:9606">human</span>
Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.
###end article-title 98
###begin article-title 99
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
###end article-title 99
###begin article-title 100
Pyruvate kinase deficiency and malaria.
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human red blood cell polymorphisms and malaria.
###end article-title 101
###begin article-title 102
The influence of inherited traits on malaria infection.
###end article-title 102
###begin article-title 103
Erythrocyte variants and the nature of their malaria protective effect.
###end article-title 103
###begin article-title 104
###xml 49 70 49 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 49 70 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Hemoglobin C modulates the surface topography of Plasmodium falciparum-infected erythrocytes.
###end article-title 104
###begin article-title 105
###xml 24 45 24 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 24 45 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots.
###end article-title 105
###begin article-title 106
###xml 91 104 91 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 91 104 <span type="species:ncbi:5833">P. falciparum</span>
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria.
###end article-title 106
###begin article-title 107
###xml 16 37 16 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 16 37 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage.
###end article-title 107
###begin article-title 108
###xml 54 75 54 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 54 75 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment.
###end article-title 108
###begin article-title 109
Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator.
###end article-title 109
###begin article-title 110
###xml 86 107 86 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 86 107 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Reduced microbicidal and anti-tumour activities of human monocytes after ingestion of Plasmodium falciparum-infected red blood cells.
###end article-title 110
###begin article-title 111
###xml 140 145 <span type="species:ncbi:9606">human</span>
Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes.
###end article-title 111
###begin article-title 112
Hemozoin is a key factor in the induction of malaria-associated immunosuppression.
###end article-title 112
###begin article-title 113
###xml 71 76 <span type="species:ncbi:9606">human</span>
Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect.
###end article-title 113
###begin article-title 114
###xml 34 55 34 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 34 55 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Host response to cytoadherence in Plasmodium falciparum.
###end article-title 114
###begin article-title 115
###xml 26 47 26 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 26 47 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin.
###end article-title 115
###begin article-title 116
###xml 51 72 51 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 51 72 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Modulation of malaria virulence by determinants of Plasmodium falciparum erythrocyte membrane protein-1 display.
###end article-title 116
###begin article-title 117
Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria.
###end article-title 117
###begin article-title 118
Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.
###end article-title 118
###begin article-title 119
###xml 18 39 18 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 18 39 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Disruption of the Plasmodium falciparum 2-Cys peroxiredoxin gene renders parasites hypersensitive to reactive oxygen and nitrogen species.
###end article-title 119
###begin article-title 120
FAD-binding site of glutathione reductase.
###end article-title 120
###begin article-title 121
The coexistence of other micronutrient deficiencies in anaemic adolescent schoolgirls in rural Bangladesh.
###end article-title 121
###begin article-title 122
###xml 61 69 <span type="species:ncbi:9606">children</span>
Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in Cote d'Ivoire.
###end article-title 122
###begin article-title 123
Riboflavin deficiency and severity of malaria.
###end article-title 123
###begin article-title 124
###xml 42 60 42 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium berghei</italic>
###xml 42 60 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 74 78 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
The influence of riboflavin deficiency on Plasmodium berghei infection in rats.
###end article-title 124
###begin article-title 125
Low red blood cell glutathione reductase and pyridoxine phosphate oxidase activities not related to dietary riboflavin: selection by malaria?
###end article-title 125
###begin article-title 126
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?
###end article-title 126
###begin article-title 127
Deficiency of two red-cell flavin enzymes in a population in Sardinia: was glutathione reductase deficiency specifically selected for by malaria?
###end article-title 127
###begin article-title 128
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.
###end article-title 128
###begin article-title 129
Glutathione reductase deficiency in association with sickle cell and thalassaemia genes in Saudi populations.
###end article-title 129
###begin article-title 130
Genetic and other influences on red-cell flavin enzymes, pyridoxine phosphate oxidase and glutathione reductase in families with beta-thalassaemia.
###end article-title 130
###begin article-title 131
Low red cell activity of pyridoxine (pyridoxamine) phosphate oxidase and glutathione reductase associated with thalassaemia.
###end article-title 131
###begin article-title 132
Depressed erythrocyte glutathione reductase activity in sickle cell disease.
###end article-title 132
###begin article-title 133
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
###end article-title 133
###begin article-title 134
Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1,3-bis(chloroethyl)-1-nitrosourea].
###end article-title 134
###begin article-title 135
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human malaria parasites in continuous culture.
###end article-title 135
###begin article-title 136
###xml 19 40 19 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 19 40 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Synchronization of Plasmodium falciparum erythrocytic stages in culture.
###end article-title 136
###begin article-title 137
Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione.
###end article-title 137
###begin article-title 138
###xml 89 94 <span type="species:ncbi:9606">human</span>
Folding of the four domains and dimerization are impaired by the Gly446->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs.
###end article-title 138
###begin article-title 139
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.
###end article-title 139
###begin article-title 140
###xml 164 185 164 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 164 185 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
###end article-title 140
###begin article-title 141
Inside-out red cell membrane vesicles: preparation and purification.
###end article-title 141
###begin article-title 142
A luminescence method for the quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and of malarial pigment.
###end article-title 142
###begin article-title 143
Innate immune and non-immune mediators of erythrocyte clearance.
###end article-title 143
###begin article-title 144
###xml 180 185 <span type="species:ncbi:9606">human</span>
Malarial pigment haemozoin, IFN-gamma, TNF-alpha, IL-1beta and LPS do not stimulate expression of inducible nitric oxide synthase and production of nitric oxide in immuno-purified human monocytes.
###end article-title 144
###begin p 145
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 145
###begin p 146
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by the German Research Council (BE1540/15-1 to KB and SFB 544 TP B2 to RHS). PA and ES were supported by grants from Compagnia di San Paolo in the context of the Italian Malaria Network, from Regione Piemonte (Progetti di Ricerca Sanitaria Finalizzata), and from the University of Turin Medical School Intramural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 146

